Advertisement

Topics

BioMed Central Ltd Company Profile

01:29 EST 15th November 2018 | BioPortfolio

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical research
All original research articles published by BioMed Central are made freely and permanently accessible online immediately upon publication. BioMed Central views open access to research as essential in order to ensure the rapid and efficient communication of research findings

Location

Science Navigation Group Middlesex House
34-42 Cleveland Street
London
London
W1T 4LB
United KIngdom

Contact

Phone: 44 (0)20 7323 0323
Fax: 44 (0)20 7631 9926
Email: info@biomedcentral.com


News Articles [147 Associated News Articles listed on BioPortfolio]

Harbour BioMed gets rights to Glenmark's bispecific antibody

Glenmark Pharmaceuticals SA granted Harbour BioMed exclusive rights to develop and sell its bispecific antibody GBR1302 for solid tumors in Greater China. Harbour BioMed also retains a manufacturing o...

Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included The p...

Siloam Biosciences to be acquired by MiCo BioMed

South Korea-based MiCo BioMed, which makes biochemical and molecular diagnostic products, announced its acquisition of Cincin -More- 

Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug

Q BioMed Inc (OTCQB: QBIO) CEO Denis Corin tells Proactive Investors the commercial-stage biotech is taking the final step in the approval process of its bone pain relief treatment, the "spearhead'"...

Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

Harbour BioMed has signed a collaboration agreement with Kelun-Biotech Biopharmaceutical to develop and commercialise A167, an anti-PD-L1 antibody indicated for...Read More... The post Deals this week...

IRW-News: RavenQuest Biomed Inc.: RavenQuest BioMed kommentiert historisches Votum des Senats hinsichtlich Verabschiedung des kanadischen Cannabis Act

IRW-PRESS: RavenQuest Biomed Inc.: RavenQuest BioMed kommentiert historisches Votum des Senats hinsichtlich Verabschiedung des kanadischen Cannabis Act RavenQuest BioMed kommentiert historisches V...

Harbour BioMed signs $350m anti-PD-L1 deal with Kelun-Biotech

Chinese companies Harbour BioMed and Sichuan Kelun-Biotech Biopharmaceutical have entered into an exclusive strategic collaboration for the development and commercialisation...Read More... The post Ha...

Glenmark partners Harbour BioMed to develop oncology candidate in China

Glenmark Pharmaceuticals has signed an exclusive licence agreement with Harbour BioMed for the development, manufacture and commercialisation of its immuno-oncology...Read More... The post Glenmark pa...

PubMed Articles [683 Associated PubMed Articles listed on BioPortfolio]

BITS 2017: the annual meeting of the Italian Society of Bioinformatics.

This preface introduces the content of the BioMed Central journal Supplement related to the 14th annual meeting of the Bioinformatics Italian Society, held in Cagliari, Italy, from the 5th to the 7th ...

Partially systematic thoughts on the history of systematic reviews.

Six years after the launch of Systematic Reviews by Biomed Central, this article is part of the celebration of the journal. It contains personal reflections on the past, present and future of systemat...

Comparison of Complication Rates of Central Venous Catheters Versus Peripherally Inserted Central Venous Catheters in Pediatric Patients.

The purpose of our study is to compare the rate of central line-associated blood stream infections and venous thromboembolism in central venous catheters versus peripherally inserted central catheters...

Quantification of the Central Cardiovascular Network Applying the Normalized Short-time Partial Directed Coherence Approach in Healthy Subjects.

The central control of the autonomic nervous system (ANS) and the complex interplay of its components can be described by a functional integrated mode - the central autonomic network (CAN). CAN repres...

Management of a Class I malocclusion with traumatically avulsed maxillary central and lateral incisors.

This case report describes orthodontic space closure for managing an avulsed maxillary central incisor and a lateral incisor in a growing girl with a Class I deep bite malocclusion with moderate lower...

Clinical Trials [1857 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

The Effect of Central Blood Pressure on Clinical Outcome in Diabetic Hypertensive Patients in Assiut University Hospitals

In recent decades, some observational studies suggest that peripheral BP measured by brachial artery may not necessarily represent BP measured in the aortic artery which is known as centra...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Direct Measurement of Ideal Depth of Central Line

Total of 89 patients undergoing elective cardiac surgery will be enrolled. Right CVC insertion begins at their intersection of the cricoid cartilage level and the triangular point where t...

The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants

This study compares two different regimens of a central line removal in respect to weight at 36 weeks postmenstrual age in very low birth weight (VLBW) preterm infants. Half of participant...

Companies [644 Associated Companies listed on BioPortfolio]

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Environmental Health journal

Environmental Health is an open access, peer-reviewed, online journal published by BioMed Central that considers manuscripts on all aspects of environmental and occupational medicine, and related stud...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

ILSI Biomed Israel 2011

The ILSI Biomed Israel 2011 is the central annual event of Israel's life science industry. It consists of an international professional conference, targeted at the best experts an...

Biomed

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

More Information about "BioMed Central Ltd" on BioPortfolio

We have published hundreds of BioMed Central Ltd news stories on BioPortfolio along with dozens of BioMed Central Ltd Clinical Trials and PubMed Articles about BioMed Central Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMed Central Ltd Companies in our database. You can also find out about relevant BioMed Central Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record